As of 2026-03-20, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -6.51 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 14.96 USD, the upside of Olema Pharmaceuticals Inc is -143.49%.
Based on its market price of 14.96 USD and our intrinsic valuation, Olema Pharmaceuticals Inc (OLMA) is overvalued by 143.49%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.51 - -6.51 | -6.51 | -143.49% |
| P/E | (30.87) - (40.03) | (33.93) | -326.8% |
| DDM - Stable | (8.06) - (28.22) | (18.14) | -221.3% |
| DDM - Multi | (6.23) - (17.67) | (9.29) | -162.1% |
| Market Cap (mil) | 1,723.93 |
| Beta | 0.23 |
| Outstanding shares (mil) | 115.24 |
| Enterprise Value (mil) | 1,691.67 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.73% |
| Cost of Debt | 5.00% |
| WACC | 7.70% |